中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2014年
9期
773-775,779
,共4页
王淑梅%孙路路%曾蔚欣%章国良
王淑梅%孫路路%曾蔚訢%章國良
왕숙매%손로로%증위흔%장국량
急性淋巴细胞白血病%细胞色素P450 2 E1%甲氨蝶呤%血清浓度
急性淋巴細胞白血病%細胞色素P450 2 E1%甲氨蝶呤%血清濃度
급성림파세포백혈병%세포색소P450 2 E1%갑안접령%혈청농도
acute lymphoblastic leukemia%cytochrome P450 2 E1%methotrexate%serum concentration
目的:考察CYP2E1*5B(G-1293C)和CYP2E1*6(T7632A)基因多态性与急性淋巴细胞白血病( ALL)易感性及其与甲氨蝶呤( MTX)血清浓度的相关性。方法收集283名健康对照者和91例ALL患儿的外周血,提取DNA。用聚合酶链反应-限制性片断长度多态性法(PCR-RFLP)检测CYP2E1*5B和CYP2E1*6基因型,用荧光偏振免疫分析法( FPIA)测定24,42 h MTX血清浓度。结果 ALL患儿的C(*5B)等位基因频率(24.73%)显著高于健康对照人群(17.31%)(P<0.05);C等位基因频率的优势比(OR)为1.57,C等位基因显著增加ALL的发病风险( P<0.05)。 ALL患儿与健康对照人群的CYP2E1*6的基因型与等位基因分布频率相近,CYP2E1*6与ALL的发病风险无显著相关关系。 CYP2E1*5B和CYP2E1*6各基因型组ALL患儿的24,42 h MTX浓度与剂量比值( C/D ratio)没有显著差异。结论 CYP2E1*5B可显著增加ALL的发病风险,但CYP2E1*6与ALL的发生无关;C等位基因是ALL的易感等位基因,两者的基因多态性与MTX血清浓度无显著相关关系。
目的:攷察CYP2E1*5B(G-1293C)和CYP2E1*6(T7632A)基因多態性與急性淋巴細胞白血病( ALL)易感性及其與甲氨蝶呤( MTX)血清濃度的相關性。方法收集283名健康對照者和91例ALL患兒的外週血,提取DNA。用聚閤酶鏈反應-限製性片斷長度多態性法(PCR-RFLP)檢測CYP2E1*5B和CYP2E1*6基因型,用熒光偏振免疫分析法( FPIA)測定24,42 h MTX血清濃度。結果 ALL患兒的C(*5B)等位基因頻率(24.73%)顯著高于健康對照人群(17.31%)(P<0.05);C等位基因頻率的優勢比(OR)為1.57,C等位基因顯著增加ALL的髮病風險( P<0.05)。 ALL患兒與健康對照人群的CYP2E1*6的基因型與等位基因分佈頻率相近,CYP2E1*6與ALL的髮病風險無顯著相關關繫。 CYP2E1*5B和CYP2E1*6各基因型組ALL患兒的24,42 h MTX濃度與劑量比值( C/D ratio)沒有顯著差異。結論 CYP2E1*5B可顯著增加ALL的髮病風險,但CYP2E1*6與ALL的髮生無關;C等位基因是ALL的易感等位基因,兩者的基因多態性與MTX血清濃度無顯著相關關繫。
목적:고찰CYP2E1*5B(G-1293C)화CYP2E1*6(T7632A)기인다태성여급성림파세포백혈병( ALL)역감성급기여갑안접령( MTX)혈청농도적상관성。방법수집283명건강대조자화91례ALL환인적외주혈,제취DNA。용취합매련반응-한제성편단장도다태성법(PCR-RFLP)검측CYP2E1*5B화CYP2E1*6기인형,용형광편진면역분석법( FPIA)측정24,42 h MTX혈청농도。결과 ALL환인적C(*5B)등위기인빈솔(24.73%)현저고우건강대조인군(17.31%)(P<0.05);C등위기인빈솔적우세비(OR)위1.57,C등위기인현저증가ALL적발병풍험( P<0.05)。 ALL환인여건강대조인군적CYP2E1*6적기인형여등위기인분포빈솔상근,CYP2E1*6여ALL적발병풍험무현저상관관계。 CYP2E1*5B화CYP2E1*6각기인형조ALL환인적24,42 h MTX농도여제량비치( C/D ratio)몰유현저차이。결론 CYP2E1*5B가현저증가ALL적발병풍험,단CYP2E1*6여ALL적발생무관;C등위기인시ALL적역감등위기인,량자적기인다태성여MTX혈청농도무현저상관관계。
Objective To investigate the relations between CYP 2E1*5B (G-1293C) and CYP2E1*6 ( T7632A) polymorphisms with the risk to develop acute lymphoblastic leukemia ( ALL) and serum concen-trations of methotrexate ( MTX ).Methods Peripheral blood samples were obtained from 283 healthy control subjects and 91 children with a-cute lymphoblastic leukemia to extract genome DNA.Polymerase chain reaction-Restriction fragment length polymorphism ( PCR-RFLP) was used to detect genotypes of CYP2E1*5B and CYP2E1*6 polymor-phisms.Fluorescence polarization immunoassay ( FPIA) was employed to determine the serum concentrations of MTX at the 24 h and 42 h.Re-sults The frequency of C (*5 B ) allele in ALL children ( 24.73%) was significantly higher than that in healthy subjects ( 17.31%) ( P<0.05 ).The odds ratio ( OR) of C allele was 1.57 , significantly increas-ing the risk to develop ALL ( P<0.05 ).There were similar frequencies of genotypes and alleles at CYP2E1*6 in healthy subjects and ALL chil-dren and the CYP2E1*6 polymorphisms were not associated with the risk to develop ALL.There were no significant differences in the dose -adjusted serum concentration ( C/D ratio ) of MTX at the 24 h and 42 h among respective genotype groups at CYP 2E1*5B and CYP2E1*6.Conclusion CYP2E1*5B significantly in-creases the risk to develop ALL and C allele is a susceptible allele for ALL.However , there are no significant associa-tions between CYP2E1*6 polymorphisms and the risk to develop ALL.CYP2E1*5B and CYP2E1*6 polymorphisms are not associated with serum concentrations of MTX in ALL children.